Effects of the Arachidonate Lipoxygenase Inhibitor BW755C on Traumatic and Peritumoural Brain Oedema
Part of the
book series (NEUROCHIRURGICA, volume 51)
The abstract BW755C is a novel non-steroidal anti-inflammatory agent. It inhibits synthesis of prostaglandins and leukotrienes by inhibition in the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism. Cold injury induced vasogenic oedema was produced in 18 cats. The animals were sacrificed at six and twenty-four hours. One group was treated with BW755C.
Seventeen white rabbits bearing an experimental brain tumour VX-2 carcinoma were treated for five consecutive days from the eighth day after tumour injection to the thirteenth day. Untreated tumour bearing rabbits were used as control.
Brain water content was measured by specific gravity method. BW755C did not reduce the water content following cold injury. There was no effect upon peritumoural oedema. The use of this novel blocking agent with diffuse effects in the arachidonic cascade was not beneficial for the reduction or prevention of brain oedema.
KeywordsBrain Oedema Brain Water Content Cold Injury Vasogenic Brain Oedema Adjacent White Matter
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Aritake K, Wakai S, Asano T, Takakura K (1983) Peroxidation of arachidonic acid and brainoedema. Brain Nerve 35: 965–973PubMedGoogle Scholar
Black KL (1984) Leukotriene C4 induces vasogenic cerebral-oedema in rats. Prostaglandins Leukotrienes Med 14: 339–340CrossRefGoogle Scholar
Black KL, Hoff JT (1985) Leukotrienes increase blood-brain barrier permeability following intraparenchymal injection in rats. Ann Neurol 18: 349–351PubMedCrossRefGoogle Scholar
Black KL, Hoff JT, McGillicuddy JE, Gebarski SS (1986) Increased leukotriene C4 and vasogenicoedema surrounding brain tumours in humans. Ann Neurol 19: 592–595PubMedCrossRefGoogle Scholar
Hambrecht GS, Adesuyi SA, Holt S, Ellis EF (1987) Brain 12 — HETE formation in different species, brain regions, and in brain microvessels. Neurochem Res 12: 1029–1033PubMedCrossRefGoogle Scholar
Higgs GA, Mugridge KG, Moncada S, Vane JR (1984) Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C. Proc Natl Acad Sci USA 81: 2890–2892PubMedCrossRefGoogle Scholar
Mayhan WG, Sahagun G, Spector R, Heistad DD (1986) Effects of leukotriene C4 on the cerebral microvasculature. Am J Physiol 251: H471 - H474PubMedGoogle Scholar
Mullane KM, Moncada S (1982) The salvage of ischaemic myocardium by BW755C in anaesthetized dogs. Prostaglandins 24: 255–266PubMedCrossRefGoogle Scholar
Shinonaga M, Chang CC, Suzuki N, Sato M, Kuwabara T (1988) Immunohistological evaluation of macrophage infiltrates in brain tumours. Correlation with peritumouraloedema. J Neurosurg 68: 259–265PubMedCrossRefGoogle Scholar
Ueno A, Tanaka K, Katori M, Hayashi MN, Arai Y (1981) Species difference in increased vascular permeability by synthetic leukotriene C4 and D4. Prostaglandins 21: 637–648PubMedCrossRefGoogle Scholar
Unterberg A, Schmidt W, Polk T, Wahl M, Ellis E, Marmarou A, Baethmann A (1987) Evidence against Leukotrienes as mediators of brainoedema. J Cereb Blood Flow Metab 7 [suppl 1]: S625Google Scholar
Unterberg A, Wahl M, Hammersen F, Baethmann A (1987) Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid. Acta Neuropathol (Berl) 73: 209–219CrossRefGoogle Scholar
Wahl M, Unterberg A, Baethmann A, Schilling L (1988) Review. Mediators of blood-brain barrier dysfunction and formation of vasogenic brainoedema. J Cereb Blood Flow Metab 8: 621–634PubMedCrossRefGoogle Scholar
Wolfe LS (1982) Eicosanoids prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon — 20 unsaturated fatty acids. J Neurochem 38: 1–14PubMedCrossRefGoogle Scholar